10X Fund, L.P. - Dec 2, 2025 Form 4 Insider Report for GALECTIN THERAPEUTICS INC (GALT)

Role
10%+ Owner
Signature
/s/ James C. Czirr, as Managing Member of the General Partner for 10X Fund, LP
Stock symbol
GALT
Transactions as of
Dec 2, 2025
Transactions value $
-$851,700
Form type
4
Date filed
12/4/2025, 04:57 PM
Previous filing
Nov 12, 2025
SEC
View on sec.gov

Reporting Owners (3)

Name Relationship Address Signature Signature date CIK
10X Fund, L.P. 10%+ Owner 545 DUTCH VALLEY ROAD, N.E., SUITE A, ATLANTA, /s/ James C. Czirr, as Managing Member of the General Partner for 10X Fund, LP 2025-12-04 0001453356
10X Capital Management, LLC 10%+ Owner 545 DUTCH VALLEY ROAD, N.E., SUITE A, ATLANTA, /s/ James C. Czirr, as Managing Member of 10X Capital Management, LLC 2025-12-04 0001457247
CZIRR JAMES C 10%+ Owner 4908 SOUTH ASHTON COURT, SPOKANE /s/ James C. Czirr, Individually 2025-12-04 0001260641

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GALT Common Stock Sale -$164K -30K -0.51% $5.47 5.8M Dec 2, 2025 Direct F1, F2
transaction GALT Common Stock Sale -$688K -120K -2.07% $5.73 5.68M Dec 3, 2025 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F2 The shares were sold in multiple transactions at prices ranging from $5.40 to $5.50. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F3 The shares were sold in multiple transactions at prices ranging from $5.68 to $5.85. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.